Key facts
- It has raised $150.0M across 1 recorded rounds; the latest was Early Stage VC (Series B) ($150.0M) in May 2024.
- 1 institutional filer reports fund marks on Septerna across 1 filings.
- Septerna has filed 1 Form D with the SEC, most recently Jul 2023 ($73.5M sold to 30 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Septerna
Create free account
No card required
Funding rounds
1 roundsMay 2024Early Stage VC (Series B)$150.0M▮
About Septerna
- Industry
- Drug Discovery
PA Mark — not yet priced
Septerna doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Septerna shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
1 filers · latest May 20261 SEC-registered fund reported 1 fair-value mark on Septerna between May 2026 and May 2026. Filer-level marks and implied $/share are available to Pro members.